Cancer Center Pasco-Pinellas is categorized under Hematologists in New Port Richey, FL and active since 1980.
Cancer Center Pasco-Pinellas was established in 1980, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Doreen Arevalo, Office Manager at the company’s single location by writing to 5347 Main St # 203, New Port Richey, Florida FL 34652 or by phoning (727) 849-6690. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cancer Center Pasco-Pinellas |
Contact Person: | Doreen Arevalo, Office Manager |
Address: | 5347 Main St # 203, New Port Richey, Florida 34652 |
Phone Number: | (727) 849-6690 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1980 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hematologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Cancer Center Pasco-Pinellas was started in 1980 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Doreen Arevalo, Office Manager for inquiries that concern Cancer Center Pasco-Pinellas by calling the company number (727) 849-6690, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Center Pasco-Pinellas can be found at the coordinates 28.250275,-82.725864 as well as the street address 5347 Main St # 203 in New Port Richey, Florida 34652.
For its online presence, you may visit Cancer Center Pasco-Pinellas’s website at and engage with its social media outlets through on Twitter and on Facebook.